BSF Enterprise (LSE:BSFA) Shares Outstanding (Basic Average): 127.68 Mil (As of Sep. 2025)


What is BSF Enterprise Shares Outstanding (Basic Average)?

BSF Enterprise LSE:BSFA -11.11% Shares Outstanding (Basic Average) is 127.68 Mil as of Sep. 2025. The stock has 3 warning signs investors should review.

Shares outstanding are shares that have been authorized, issued, and purchased by investors and are held by them. BSF Enterprise's average basic shares outstanding for the quarter that ended in Sep. 2025 was 127.68 Mil.

BSF Enterprise  (LSE:BSFA) Shares Outstanding (Basic Average) Explanation

A company may buy back shares or issue shares in any fiscal period. If a company buys back shares, we should observe that the total number of shares decline. If the company issues new shares, the number of shares outstanding increases.

Be Aware

Usually the presence of treasury shares and a history of buyback are good indicators that company has competitive advantage. But studies have shown that companies usually buy back at wrong time. Buying back shares below its intrinsic value increases value for remaining shareholders. Buying back overvalued shares destroys value for existing shareholders.

BSF Enterprise Shares Outstanding (Basic Average) Related Terms

BSF Enterprise Shares Outstanding (Basic Average) Historical Data

* Premium members only.

The historical data trend for BSF Enterprise's Shares Outstanding (Basic Average) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

BSF Enterprise Shares Outstanding (Basic Average) Chart

BSF Enterprise Annual Data
Trend Sep19 Sep20 Sep21 Sep22 Sep23 Sep24 Sep25
Shares Outstanding (Basic Average)
Get a 7-Day Free Trial 20.34 45.11 94.65 103.34 122.12

BSF Enterprise Semi-Annual Data
Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25
Shares Outstanding (Basic Average) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 103.03 103.34 103.34 116.55 127.68

BSF Enterprise Shares Outstanding (Basic Average) Calculation

Shares outstanding are shares that have been authorized, issued, and purchased by investors and are held by them. They have voting rights and represent ownership in the corporation by the person that holds the shares. They should be distinguished from treasury shares, which are shares held by the corporation itself, having no exercisable rights.

Shares outstanding can be calculated as either basic or fully diluted. The fully diluted shares outstanding count includes diluting securities, such as options, warrants or convertibles.

Please note: GuruFocus named Shares Outstanding (EOP) is the shares for that exact time point. It is usually used to calculate balance sheet related items, such as Book Value per Share, etc. While Shares Outstanding (Diluted Average) and Shares Outstanding (Basic Average) are the weighted average shares over a period of time (a year, a quarter, or so). They are usually used to calculate income statement or cashflow statement related items, such as Earnings per Share (Diluted), etc.

What does a Shares Outstanding (Basic Average) of 127.68 Mil mean?
BSF Enterprise (LSE:BSFA) has a Shares Outstanding (Basic Average) of 127.68 Mil as of Sep. 2025. The average shares outstanding over two periods not accounting for dilutive securities like convertible bonds. View historical data on BSF Enterprise and its competitors.
Is BSF Enterprise's Shares Outstanding (Basic Average) too high?
BSF Enterprise's current Shares Outstanding (Basic Average) is 127.68 Mil.
How does BSF Enterprise's Shares Outstanding (Basic Average) compare to VRTX and REGN?
BSF Enterprise's Shares Outstanding (Basic Average) of 127.68 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Shares Outstanding (Basic Average) for a Biotechnology company?
A good Shares Outstanding (Basic Average) depends on the Biotechnology industry context. However, Shares Outstanding (Basic Average) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Shares Outstanding (Basic Average) mean?
A high Shares Outstanding (Basic Average) can signal that a stock is expensive relative to its fundamentals. The average shares outstanding over two periods not accounting for dilutive securities like convertible bonds. View historical data on BSF Enterprise and its competitors. BSF Enterprise's current Shares Outstanding (Basic Average) is 127.68 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BSF Enterprise stock overvalued right now?
BSF Enterprise (LSE:BSFA) has a current Shares Outstanding (Basic Average) of 127.68 Mil. The current Shares Outstanding (Basic Average) is 127.68 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Shares Outstanding (Basic Average) calculated?
Shares Outstanding (Basic Average) is calculated from a company's financial statements. For BSF Enterprise (LSE:BSFA), the current Shares Outstanding (Basic Average) is 127.68 Mil as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

BSF Enterprise Business Description

Address 2 Portman Street, London, GBR, W1H 6DU
BSF Enterprise PLC is a United Kingdom-based biotech company. The Company is focused on developing biotechnological solutions using cell-based tissue engineering to help generate cultured meat, lab-grown leather, as well as human corneas, collagen growth and skin substitutes. The Company operates through its wholly owned subsidiary, 3D Bio-Tissues Limited (3DBT), which is a clinical and cellular agriculture company engaged in producing human corneas that could help restore vision to millions of people.